Document is current

Any future updates will be listed below

Assessment of efficacy, safety and quality of life of 110 patients treated with sunitinib as first-line therapy for metastatic renal cell carcinoma: experience in real-world clinical practice in Japan

Crossref DOI link: https://doi.org/10.1007/s12032-014-0978-4

Published Online: 2014-05-04

Published Print: 2014-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark